From: Avipoxviruses: infection biology and their use as vaccine vectors
Recombinant viral vector | Targeted pathogen/disease | Inserts | Vaccine details | Developer/Sponsors | Clinical phase | References |
---|---|---|---|---|---|---|
ALVAC containing the gene encoding HIV-1 gp160, and protein gp120 | HIV-1 | gp160 and gp120 | ALVAC-HIV vCP1521 prime and AIDSVAX-gp120 subtype B/E boost | U.S. Army Medical Research and Materiel Command | III | [141] |
ALVAC-HIV (vCP1452) and LIPO-5+vCP1452 | HIV-1 | LIPO-5 | ALVAC-HIV (vCP1452) LIPO-5 | NIH | I/II | [142] |
VACV and ALVAC or FWPV with or without combination therapy | Cancer | CEA (pancarcinoma) | TRICOM vectors co-express B7.1, ICAM1 and LFA3 | NIH | I/II | [143] |
FWPV (FP9) | Malaria | Circumsporozoite (CSP) protein | Attenuated FP9 and Circumsporozoite (CSP) protein | Gates Malaria Partnership | I | [144] |